大模型重塑千行百业的今天，医疗领域却面临一个现实命题：当通用AI遇上临床的 "严谨刚需"，如何让算法真正听懂医生的话、嵌入诊疗的流程？这正是 医疗AI从"可用"走向"实用"的核心关卡。 智通财经APP获悉，近日，医渡科技（02158）高级副总裁、科研业务线总经理黄楠博士，技术创新副总裁、AI架构师李林峰博士共同出席中国老年保健医 学研究会数智健康分会2025年会暨清华心血管教育培训课程，以"大模型临床助手赋能专科诊疗提质增效"为核心，分享了医渡科技的深耕实践。 人工智能与医疗健康领域的融合正在全面提速。然而，通用大模型在直接服务临床决策时，面临"幻觉"风险、过程不透明、缺乏医疗严谨性等根本问题。 医渡科技的解题思路，是进行一场面向临床实用性的系统性重构，让AI的"思考"过程变得可控、可信、可溯源。公司以自研医疗垂域大模型"YiduCore"为核 心，打造了"大数据+大模型"双中台解决方案，为医院打造高质量发展的坚实数字底座。 其中，AI中台的核心价值，在于可将大模型的原始能力系统性转化为符合医疗规范、理解临床流程、知晓专科知识的"智能体"，从而实现AI在真实医院场景 中的"落地生根"。 让智能伙伴无缝融入工作 ...

Core Viewpoint - 医渡科技 is actively repurchasing its shares, indicating confidence in its market position and future growth potential [1] Group 1: Share Buyback Activity - On October 22, 医渡科技 repurchased 17,700 shares for a total of 100,000 HKD [1] - Since September 26, the company has completed 8 share buybacks, with a total expenditure exceeding 20.4 million HKD [1] Group 2: Southbound Capital Inflows - On October 17, southbound funds net purchased 4.035 million shares of 医渡科技, accounting for 28.56% of the day's trading volume [1] - The net purchase amount by southbound funds on that day was approximately 22.88 million HKD, marking six consecutive days of net buying, with a cumulative total of 100 million HKD [1] Group 3: Product Development and Implementation - 医渡科技 recently launched "Doctor Clinical Copilot," which has developed 25 intelligent scenarios, enabling a comprehensive process from intelligent medical record generation to patient education and smart nursing [1] - The self-developed "医渡大模型" and intelligent solutions have been implemented in over 110 hospitals nationwide [1]

Core Viewpoint - The company, Yidu Tech, has been actively repurchasing its shares, indicating confidence in its market position and future growth potential [1] Group 1: Share Buyback Activity - On October 21, Yidu Tech repurchased nearly 60,000 shares at a cost of 340,000 Hong Kong dollars [1] - From September 26 to the present, the company has completed seven share buybacks, with a total expenditure exceeding 20.3 million Hong Kong dollars [1] Group 2: Product Development - Yidu Tech recently launched the "Doctor Clinical Copilot," which has undergone extensive refinement across 25 intelligent scenarios [1] - The product enables a comprehensive process from intelligent medical record generation, AI pre-consultation, evidence-based decision support, to patient education and smart nursing [1] - It allows doctors to customize personalized assistants, achieving an "All in One" smart support solution [1]

Group 1 - Company has been actively repurchasing shares, with a recent buyback on October 21 amounting to 340,000 HKD for nearly 60,000 shares [1] - Since September 26, the company has completed 7 buybacks, totaling over 20.3 million HKD [1] - As of October 21, the company's stock price closed at 5.69 HKD, reflecting a 1.07% increase [1] Group 2 - The company recently launched "Doctor Clinical Copilot," which has developed 25 intelligent scenarios, enabling a full process from intelligent medical record generation to patient education and smart care [1] - The self-developed "Yidu Big Model" and intelligent solutions have been implemented in over 110 hospitals nationwide [1]

Group 1 - Company has been actively repurchasing shares, with a recent buyback on October 21 amounting to 340,000 HKD for nearly 60,000 shares [1] - Since September 26, the company has completed 7 buybacks, totaling over 20.3 million HKD [1] - As of October 21, the company's stock price closed at 5.69 HKD, reflecting a 1.07% increase [1] Group 2 - The company recently launched "Doctor Clinical Copilot," which has developed 25 intelligent scenarios, enabling a full process from intelligent medical record generation to patient education and smart care [1] - The self-developed "Yidu Big Model" and intelligent solutions have been implemented in over 110 hospitals nationwide [1]